|
⚲
|
| Keyboard |
| Timothy Coughlin | |
|---|---|
| Firm | |
| Address | c/o Fate Therapeutics, Inc 3535 General Atomics Court, Suite 200 San Diego, CA 92121 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Fate Therapeutics Inc | 021-370287 | Director | 50.0 M of 50.0 M |
||
| Fate Therapeutics Inc | 021-365465 | Director | 50.0 M of 50.0 M |
||
| ATYR Pharma Inc | 021-294795 | Director | 45.8 M of 45.8 M |
||
| Fate Therapeutics Inc | 021-275847 | Director | 56.7 M of 56.7 M |
||
| Fate Therapeutics Inc | 021-269268 | Director | 10.3 M of 10.3 M |
||
| Fate Therapeutics Inc | 021-240107 | Director | 8.0 M of 8.0 M |
||
| Tigris Resources Ltd | 021-200528 | Executive Officer | 2.6 M of 2.6 M |
||
| Lydian International Ltd | 021-175420 | Executive Officer | 0.1 M of 0.1 M |
||
| Lydian International Ltd | 021-149874 | Executive Officer | 19.8 M of 19.8 M |
||
| Lydian International Ltd | 021-141239 | Executive Officer | 2.5 M of 2.5 M |
||